Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page shows an updated revision label from v3.5.4 to v3.5.5, reflecting a version update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-08T04:15:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a new release version; no substantive changes to the displayed study information are evident.
    Difference
    0.1%
    Check dated 2026-05-17T10:14:31.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a maintenance or platform update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-25T18:52:01.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:45:53.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Version update from v3.4.3 to v3.5.0; study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:20.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision 3.4.3 was added and 3.4.2 was removed. No study details or interactive elements appear to be altered.
    Difference
    0.1%
    Check dated 2026-03-06T18:20:45.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.